JNBA Financial Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $293K | Sell |
6,863
-92
| -1% | -$5K | 0.02% | 176 |
|
|
2026
Q1 | $436K | Buy |
6,955
+92
| +1% | +$7.36K | 0.04% | 144 |
|
|
2025
Q4 | $654K | Sell |
6,863
-552
| -7% | -$54.1K | 0.06% | 129 |
|
|
2025
Q3 | $724K | Buy |
7,415
+552
| +8% | +$57.2K | 0.07% | 118 |
|
|
2025
Q2 | $737K | Hold |
6,863
| – | – | 0.07% | 107 |
|
|
2025
Q1 | $692K | Hold |
6,863
| – | – | 0.07% | 113 |
|
|
2024
Q4 | $613K | Hold |
6,863
| – | – | 0.06% | 120 |
|
|
2024
Q3 | $575K | Sell |
6,863
-435
| -6% | -$34.3K | 0.06% | 122 |
|
|
2024
Q2 | $562K | Buy |
7,298
+435
| +6% | +$31.8K | 0.06% | 123 |
|
|
2024
Q1 | $470K | Sell |
6,863
-62
| -0.9% | -$3.99K | 0.05% | 136 |
|
|
2023
Q4 | $400K | Sell |
6,925
-64
| -0.9% | -$3.42K | 0.05% | 149 |
|
|
2023
Q3 | $369K | Buy |
6,989
+64
| +0.9% | +$3.36K | 0.05% | 144 |
|
|
2023
Q2 | $375K | Hold |
6,925
| – | – | 0.04% | 147 |
|
|
2023
Q1 | $346K | Buy |
6,925
+62
| +0.9% | +$2.92K | 0.05% | 154 |
|
|
2022
Q4 | $318K | Sell |
6,863
-921
| -12% | -$39.9K | 0.04% | 157 |
|
|
2022
Q3 | $301K | Hold |
7,784
| – | – | 0.05% | 155 |
|
|
2022
Q2 | $290K | Hold |
7,784
| – | – | 0.04% | 154 |
|
|
2022
Q1 | $345K | Hold |
7,784
| – | – | 0.05% | 151 |
|
|
2021
Q4 | $331K | Hold |
7,784
| – | – | 0.04% | 159 |
|
|
2021
Q3 | $338K | Hold |
7,784
| – | – | 0.05% | 155 |
|
|
2021
Q2 | $333K | Buy |
7,784
+671
| +9% | +$28.2K | 0.05% | 155 |
|
|
2021
Q1 | $275K | Buy |
7,113
+250
| +4% | +$9.46K | 0.04% | 163 |
|
|
2020
Q4 | $247K | Hold |
6,863
| – | – | 0.04% | 156 |
|
|
2020
Q3 | $262K | Hold |
6,863
| – | – | 0.05% | 134 |
|
|
2020
Q2 | $241K | Sell |
6,863
-435
| -6% | -$15.7K | 0.05% | 138 |
|
|
2020
Q1 | $238K | Hold |
7,298
| – | – | 0.06% | 126 |
|
|
2019
Q4 | $330K | Hold |
7,298
| – | – | 0.06% | 117 |
|
|
2019
Q3 | $297K | Sell |
7,298
-100
| -1% | -$4.24K | 0.06% | 118 |
|
|
2019
Q2 | $318K | Buy |
7,398
+100
| +1% | +$3.85K | 0.06% | 119 |
|
|
2019
Q1 | $280K | Hold |
7,298
| – | – | 0.06% | 123 |
|
|
2018
Q4 | $258K | Buy |
+7,298
| New | +$265K | 0.06% | 114 |
|
|
2018
Q3 | – | Sell |
-7,298
| Closed | -$239K | – | 513 |
|
|
2018
Q2 | $239K | Hold |
7,298
| – | – | 0.05% | 120 |
|
|
2018
Q1 | $199K | Hold |
7,298
| – | – | 0.04% | 126 |
|
|
2017
Q4 | $181K | Hold |
7,298
| – | – | 0.04% | 133 |
|
|
2017
Q3 | $213K | Hold |
7,298
| – | – | 0.05% | 116 |
|
|
2017
Q2 | $202K | Hold |
7,298
| – | – | 0.05% | 115 |
|
|
2017
Q1 | $182K | Hold |
7,298
| – | – | 0.04% | 123 |
|
|
2016
Q4 | $158K | Buy |
7,298
+6,013
| +468% | +$131K | 0.04% | 131 |
|
|
2016
Q3 | $31K | Sell |
1,285
-6,013
| -82% | -$143K | ﹤0.01% | 664 |
|
|
2016
Q2 | $171K | Hold |
7,298
| – | – | 0.05% | 126 |
|
|
2016
Q1 | $137K | Hold |
7,298
| – | – | 0.05% | 130 |
|
|
2015
Q4 | $135K | Hold |
7,298
| – | – | 0.05% | 129 |
|
|
2015
Q3 | $120K | Hold |
7,298
| – | – | 0.05% | 128 |
|
|
2015
Q2 | $129K | Buy |
7,298
+435
| +6% | +$7.77K | 0.05% | 114 |
|
|
2015
Q1 | $122K | Hold |
6,863
| – | – | 0.05% | 117 |
|
|
2014
Q4 | $91K | Hold |
6,863
| – | – | 0.04% | 142 |
|
|
2014
Q3 | $81K | Hold |
6,863
| – | – | 0.04% | 153 |
|
|
2014
Q2 | $88K | Hold |
6,863
| – | – | 0.04% | 141 |
|
|
2014
Q1 | $93K | Hold |
6,863
| – | – | 0.05% | 122 |
|
|
2013
Q4 | $82K | Sell |
6,863
-200
| -3% | -$2.36K | 0.04% | 135 |
|
|
2013
Q3 | $83K | Hold |
7,063
| – | – | 0.05% | 128 |
|
|
2013
Q2 | $65K | Buy |
+7,063
| New | +$59.9K | 0.04% | 137 |
|
Other funds holding BSX
ATO
RG
YIH
BPC
FFM
BPCE
JNBA Financial Advisors's BSX Position: Q2 2026 in Review
JNBA Financial Advisors reduced its Boston Scientific (BSX) stake by 1.3% in Q2 2026, selling an estimated $5K and leaving 6,863 shares worth $293K. The position accounts for 0.02% of the portfolio, ranked #176.
JNBA Financial Advisors first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $737K in Q2 2025. 391 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- JNBA Financial Advisors held 6,863 shares of Boston Scientific worth $293K as of Q2 2026.
- JNBA Financial Advisors sold 92 Boston Scientific shares in Q2 2026, an estimated $5K.
- Boston Scientific made up 0.02% of JNBA Financial Advisors's portfolio in Q2 2026, its #176 holding.
- JNBA Financial Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- JNBA Financial Advisors's Boston Scientific position peaked at $737K in Q2 2025.
- 391 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.